Covington Capital Management’s Takeda Pharmaceutical TAK Stock Holding History

Covington Capital Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,335	Closed	-$33K	–	1183
2022 Q1	$33K	Hold	2,335	–	–	﹤0.01%	641
2021 Q4	$32K	Hold	2,335	–	–	﹤0.01%	603
2021 Q3	$38K	Hold	2,335	–	–	﹤0.01%	583
2021 Q2	$39K	Hold	2,335	–	–	﹤0.01%	576
2021 Q1	$43K	Hold	2,335	–	–	﹤0.01%	495
2020 Q4	$42K	Hold	2,335	–	–	﹤0.01%	485
2020 Q3	$42K	Hold	2,335	–	–	﹤0.01%	458
2020 Q2	$42K	Hold	2,335	–	–	﹤0.01%	455
2020 Q1	$35K	Hold	2,335	–	–	﹤0.01%	458
2019 Q4	$46K	Sell	2,335 -145	-6%	-$2.77K	﹤0.01%	484
2019 Q3	$43K	Buy	2,480 +145	+6%	+$2.51K	﹤0.01%	461
2019 Q2	$41K	Hold	2,335	–	–	﹤0.01%	457
2019 Q1	$48K	Buy	+2,335	New	+$47K	﹤0.01%	437

Other funds holding TAK

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Covington Capital Management's TAK Position: Q2 2022 in Review

Covington Capital Management sold out of Takeda Pharmaceutical (TAK) in Q2 2022, closing a stake of 2,335 shares — an estimated $33K sold.

Covington Capital Management first reported a position in TAK in Q1 2019 and held it in 13 quarters. The position peaked at $48K in Q1 2019. 283 funds tracked by Wall St. Rank hold TAK as of Q2 2022.

Covington Capital Management reported no remaining Takeda Pharmaceutical position as of Q2 2022 after selling out during the quarter.
Covington Capital Management sold 2,335 Takeda Pharmaceutical shares in Q2 2022, an estimated $33K.
Covington Capital Management first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 13 quarters.
Covington Capital Management's Takeda Pharmaceutical position peaked at $48K in Q1 2019.
283 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2022.

Based on Covington Capital Management's 13F filing for Q2 2022, filed 8 Jul 2022.